• Bae, J., Yang, L. & Rezaie, A.R. (2007) Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells. Proceedings of the National Academy of Sciences of the United States of America, 104, 28672872.
  • Bom, V.J. & Bertina, R.M. (1990) The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII. Biochemical Journal, 265, 327336.
  • Butenas, S. & Mann, K.G. (1996) Kinetics of human factor VII activation. Biochemistry, 35, 19041910.
  • Fukudome, K. & Esmon, C.T. (1994) Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. Journal of Biological Chemistry, 269, 2648626491.
  • Fukudome, K., Ye, X., Tsuneyoshi, N., Tokunaga, O., Sugawara, K., Mizokami, H. & Kimoto, M. (1998) Activation mechanism of anticoagulant protein C in large blood vessels involving the endothelial cell protein C receptor. Journal of Experimental Medicine, 187, 10291035.
  • Ghosh, S., Pendurthi, U.R., Steinoe, A., Esmon, C.T. & Rao, L.V. (2007) Endothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium. Journal of Biological Chemistry, 282, 1184911857.
  • Hurtado, V., Montes, R., Gris, J.C., Bertolaccini, M.L., Alonso, A., Martínez-González, M.A., Khamashta, M.A., Fukudome, K., Lane, D.A. & Hermida, J. (2004) Autoantibodies against EPCR are found in antiphospholipid syndrome and are a risk factor for fetal death. Blood, 104, 13691374.
  • Ireland, H., Konstantoulas, C.J., Cooper, J.A., Hawe, E., Humphries, S.E., Mather, H., Goodall, A.H., Hogwood, J., Juhan-Vague, I., Yudkin, J.S., Di Minno, G., Margaglione, M., Hamsten, A., Miller, G.J., Bauer, K.A., Kim, Y.T., Stearns-Kurosawa, D.J. & Kurosawa, S. (2005) EPCR Ser219Gly: elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitro. Atherosclerosis., 183, 283292.
  • Ireland, H.A., Cooper, J.A., Drenos, F., Acharya, J., Mitchell, J.P., Bauer, K.A., Morrissey, J.H., Esnouf, M.P. & Humphries, S.E.. (2009) FVII, FVIIa, and Downstream Markers of Extrinsic Pathway Activation Differ by EPCR Ser219Gly Variant in Healthy Men. Arteriosclerosis, Thrombosis and Vascular Biology, doi: 10.1161/ATVBAHA.109.191551.
  • Komiyama, Y., Pedesen, A.H. & Kisiel, W. (1990) Proteolytic activation of human factors IX and X by recombinant human factor VIIa: effects of calcium, phospholipids, and tissue factor. Biochemistry, 29, 94189425.
  • Laszik, Z., Mitro, A., Taylor, Jr, F.B., Ferrell, G. & Esmon, C.T. (1997) Human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway. Circulation, 96, 36333640.
  • Laszik, Z.G., Zhou, X.J., Ferrell, G.L., Silva, F.G. & Esmon, C.T. (2001) Down-regulation of endothelial expression of endothelial cell protein C receptor and thrombomodulin in coronary atherosclerosis. American Journal of Pathology, 159, 797802.
  • Liaw, P.C., Neuenschwander, P.F., Smirnov, M.D. & Esmon, C.T. (2000) Mechanisms by which soluble endothelial cell protein C receptor modulates protein C and activated protein C function. Journal of Biological Chemistry, 275, 54475452.
  • López-Sagaseta, J., Montes, R., Puy, C., Díez, N., Fukudome, K. & Hermida, J. (2007) Binding of factor VIIa to the endothelial cell protein C receptor reduces its coagulant activity. Journal of Thrombosis and Haemostasis, 5, 18171824.
  • Mackman, N. (2006) Role of tissue factor in hemostasis and thrombosis. Blood Cells, Molecules and Diseases, 36, 104107.
  • Medina, P., Navarro, S., Estellés, A., Vayá, A., Woodhams, B., Mira, Y., Villa, P., Migaud-Fressart, M., Ferrando, F., Aznar, J., Bertina, R.M. & España, F. (2004) Contribution of polymorphisms in the endothelial protein C receptor gene to soluble endothelial protein C receptor and circulating activated protein C levels, and thrombotic risk. Thrombosis and Haemostasis, 91, 905911.
  • Medina, P., Navarro, S., Estellés, A., Vayá, A., Bertina, R.M. & España, F. (2005) Influence of the 4600A/G and 4678G/C polymorphisms in the endothelial protein C receptor (EPCR) gene on the risk of venous thromboembolism in carriers of factor V Leiden. Thrombosis and Haemostasis, 94, 389394.
  • Navarro, S., Medina, P., Mira, Y., Estellés, A., Villa, P., Ferrando, F., Vayá, A., Bertina, R.M. & España, F. (2008) Haplotypes of the EPCR gene, prothrombin levels, and the risk of venous thrombosis in carriers of the prothrombin G20210A mutation. Haematologica, 93, 13581363.
  • Nemerson, Y. (1988) Tissue factor and hemostasis. Blood, 71, 19711978.
  • Preston, R.J., Ajzner, E., Razzari, C., Karageorgi, S., Dua, S., Dahlback, B. & Lane, D.A. (2006) Multifunctional specificity of the protein C/activated protein C Gla domain. Journal of Biological Chemistry, 281, 2885028857.
  • Qu, D., Wang, Y., Song, Y., Esmon, N.L. & Esmon, C.T. (2006) The Ser219 – >Gly dimorphism of the endothelial protein C receptor contributes to the higher soluble protein levels observed in individuals with the A3 haplotype. Journal of Thrombosis and Haemostasis, 4, 229235.
  • Saposnik, B., Reny, J.L., Gaussem, P., Emmerich, J., Aiach, M. & Gandrille, S. (2004) A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis. Blood, 103, 13111318.
  • Uitte de Willige, S., Van Marion, V., Rosendaal, F.R., Vos, H.L., De Visser, M.C. & Bertina, R.M. (2004) Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis. Journal of Thrombosis and Haemostasis, 2, 13051310.
  • Zwaal, R.F., Comfurius, P. & Bevers, E.M. (1998) Lipid-protein interactions in blood coagulation. Biochimica et Biophysica Acta, 1376, 433453.
  • Zwaal, R.F., Comfurius, P. & Bevers, E.M. (2005) Surface exposure of phosphatidylserine in pathological cells. Cellular and Molecular Life Sciences, 62, 971988.